Department of Oral and Maxillofacial Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Department of Oral and Maxillofacial Surgery, Niigata Hospital, The Nippon Dental University, 1-8 Hamauracho, Chuo-ku, Niigata, 951-8580, Japan.
Oral Radiol. 2019 Jan;35(1):77-83. doi: 10.1007/s11282-018-0319-y. Epub 2018 Feb 5.
We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m and cisplatin, total of 175 mg/m), cetuximab (initial dose of 400 mg/m with subsequent weekly doses of 250 mg/m intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.
我们在此报告一例 63 岁男性颊黏膜鳞状细胞癌伴 N3 颈淋巴结转移病例。该患者接受了联合治疗,包括放疗(2 Gy/天,总量 70 Gy)、经颞浅动脉超选择性动脉内化疗(多西他赛,总量 70 mg/m2 及顺铂,总量 175 mg/m2)、西妥昔单抗(初始剂量 400 mg/m2,随后每周静脉内给予 250 mg/m2)和 4 次颈部淋巴结转移的高热治疗。患者对治疗反应良好,原发肿瘤完全缓解。行根治性颈淋巴结清扫术,并进行了包括皮肤切除的重建手术。N3 和所有其他颈部淋巴结转移均达到病理完全缓解。治疗后 3 年患者未出现复发迹象。基于本病例的发现,逆行超选择性动脉内放化疗联合高热和西妥昔单抗治疗似乎是口腔癌 N3 颈淋巴结转移患者的一种有前途的治疗方法。